This presentation reviews the challenges in characterization, categorization, and dosage of botanical Cannabis.
About the event
Beta-Caryophyllene (BCP) is found in many nutritious herbs such as black pepper, cinnamon and hemp and is responsible for many of the benefits of those foods. FDA has even approved BCP as saTraditional prohibitive attitudes to Cannabis have shifted. New laws are asking clinicians to evaluate the medical use of Cannabis. Due to social context and the paucity of clinical research studies, the Cannabis user has been alienated from science. As well, patients are challenged by unvalidated, marketed Cannabis products. As a primary objective, the clinician is introduced into this relationship for safety. Applying open minded observations to trial-and-error interventions has served the Cannabis user for a long time. Thus, the clinician bridges the culture and experience of the Cannabis user with a scientific paradigm to both learn from patients and guide them toward safe and efficacious treatment. In this presentation I review the challenges in characterization, categorization, and dosage of botanical Cannabis.